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For ever 20 years, physicians specialising in a range of clinical
areas, especially those working with chronic patients, have shown
an increasing interest in health related quality of life evaluation
(Testa and Simonson, 1996). The term quality of life can be
interpreted as an attribute or a set of attributes inherent to a
characteristic that permits this to be perceived as equal, better or
worse than others of the same type (Definition of «Real Academia
de la Lengua Española», 1984). In addition, the term of having
diverse uses in the specialized scientific literature has, over the last
decade, different meanings, such as relative conditions to the well-
being, comfort, subjectivity, and multidimensionality (Padierna
Sanchez, Fernández Rodríguez and González Menéndez, 2002). It
has been observed in the last fifteen years an important increment
of investigations in diverse fields like health, mental health,
education, disablity, labor world and services (Verdugo and Sabeh,
2002). Liver transplantation is currently considered to be the
elective treatment for end-stage liver disease and approximately
80% of patients survive longer than one year post-transplantation
and 61% have a survival of 8 years (Nickel, Wunsch, Egle, Lohse
and Otto, 2002). Therefore, as well as knowing the survival of
liver transplant recipients or patients diagnosed with chronic
disease such as hepatic cirrhotics, it is also interesting to assess
their health status in affective, psychological, emotional, social
and work-related areas (Gill and Feinstein, 1994). Moreover, in
clinical practise the physician is often ignorant of important
changes taking place in their patients’ all-round functioning (Deyo
and Patrick, 1989). 
A good evaluation of QOL is one that measures the health
status on a wellbeing scale that covers aspects such as satisfaction,
general perception of health, psychological wellbeing, physical
wellbeing and disease and death. However, it should also include
aspects that are not directly health-related such as: work, family,
friends and other circumstances in the patients’ lives (Gill and
Feinstein, 1994; Patrick and Erickson, 1987). Moreover, QOL
evaluation in transplanted patients is also interesting from the
Health Service perspective because of the cost-benefit of surgical
intervention as a treatment for these patients (Younossi and
Guyatt, 1998).
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This study analyses the health related quality of life in patients diagnosed with hepatic cirrhosis (HC)
in the three Child-Pugh stages (A, B and C) and in liver transplant recipients (OLT). Health related
quality of life was quantified by the multidimensional psychometric test PLC (Siegrits, Boer and Jun-
ge, 1996). In general, patients HC and OLT had a poorer scores than the control group in Physical Well-
being, Physical Function, Positive Mood, Negative Mood and Psychological Wellbeing scales. Also,
patients with OLT present a better quality of life than patients with advanced cirrhosis (Child B and C)
in scales that evaluate Physical, Psychological and Social functions. The OLT group even obtained hig-
her scores in the Positive Mood scale than Child-A cirrhotics. Our results suggest that although qua-
lity of life in OLT patients does not reach levels of healthy individuals, it is significantly better than in
cirrhotic patients, especially than those in advanced stages. 
Calidad de vida en pacientes cirróticos y trasplantados hepáticos. Este estudio analiza la calidad de
vida relacionada con la salud en pacientes diagnosticados de cirrosis hepática (CH) en los tres estadios
Child-Pugh (A, B y C) y en pacientes trasplantados (OLT). La calidad de vida ha sido cuantificada por
la prueba psicométrica multidimensional PLC (Siegrits, Boer and Junge, 1996). En general, los pa-
cientes CH y OLT presentaron peores puntuaciones que el grupo control en las dimensiones de Capa-
cidad física, Función física, Ánimo positivo, Ánimo negativo y Bienestar psicológico. Aunque los pa-
cientes OLT mostraron mejor calidad de vida que los pacientes con estados avanzados de cirrosis
(Child B y C) en las escalas que evalúan las funciones física, psicológica y social. El grupo OLT pre-
sentan puntuaciones más altas en la dimensión Ánimo positivo respecto al grupo de pacientes cirróti-
cos en estadio Child A. Nuestros resultados sugieren que la calidad de vida en pacientes OLT no al-
canza los niveles de la población sana, pero es significativamente mejor que en pacientes CH
especialmente en fases avanzadas.
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The aim of this work is to assess quality of life in liver
transplant recipients compared to that of cirrhotic patients and
healthy individuals in its physical, social and psychological
dimensions not directly related with liver function and clinical
manifestations. For this purpose we chose a test, the PLC, that we
consider to cover all the areas we wish to assess. 
Material and methods
Subjects
A total of 150 patients were studied, 128 men and 22 women,
with an average age of 56.2 ± 9.2 years. A total of 89 were
diagnosed with hepatic cirrhosis and were classified into 30
patients in Child-Pugh A, 30 in Child-Pugh B and 29 in Child-
Pugh C. Cirrhosis was diagnosed according to standard clinical
and analytical criteria (Conn, 1981) and confirmed by liver biopsy
when permitted by coagulation parameters (70% of cases).
Hepatic cirrhosis aetiology was excess alcohol consumption in
63%, a combination of alcohol intake and viral in 18%, only viral
in 12% and 7% were due to other causes. The second group was
comprised of 30 patients who had received a liver transplant
because of a previous cirrhosis. Their pre-transplant aetiology
was: 40% ethylic, 36% viral and 10% from other causes; 10% of
patients had post-transplant liver disease. The control group (CG)
was comprised of 31 health volunteer blood donors. The
demographic, clinical and epidemiological characteristics of the
study participants are given in Table 1. All participants gave their
consent in writing for the study and were continually informed of
the study objectives.
Methods
The Profile of Quality of Life in the Chronically Ill (PLC)
(Siegrits, Boer and Junge, 1996) is a data collection instrument
based on a well-known modular system. It consists of a central
module with 40 items that measure 6 dimensions: 
Physical capacity: 8 items, Psychological function: 8 items,
Social function: 6 items, Positive mood status: 5 items, Negative
mood status: 8 items, Social wellbeing: 5 items (see Table 2). It
also has a variable module that covers aspects related to the chronic
disease concerned, in this case liver disease. As well as the central
module and the symptom list there is also a standardised record of
the most important sociodemographic characteristics of the patients
interviewed. The PLC have the following parts: central module
(basic nucleus of the test), symptom list (specific to each disease)
and sociodemographic appendix (including extra questions). In this
study we used the PLC version validated for the Spanish
population by Fernández-López and Hernández-Mejía (1997).
Process
Data for quality of life evaluation were collected from
outpatients attending the Out Patients Clinic of the Digestive
Medicine Service of the Central Hospital of Asturias, from
September 1999 to December 2000. After the clinical check-up,
patients were assessed for QOL and classified according to their
Child-Pugh grade at that moment. 
The group of liver transplant recipients (OLT) were chosen at
random from all the patients in post-transplantation follow-up in
the Hospital. The average time elapsed from transplantation until
QOL evaluation was 2.5 years (range 9-36 months). The control
group (CG) was comprised of 31 healthy volunteer blood donors.
This choice of control group ruled out the possibility of liver
disease because of the periodic analytical tests these subjects had
to undertake. Age, sex and cultural level of these individuals were
similar to the cirrhotic and liver transplant groups (see Table 1).
Statistical Analysis
Differences between the sample groups in the dimensions that
assess quality of life were studied by multivariate variance analysis
followed by a Univariate Variance Analysis, with a posteriori
between-group comparisons using the Sfheffe test, with a statistical
significance of p<0.05. Statistical analyses were performed using
the statistical package SPSS for Windows, version 8.5.0.
Results
The scores for the scales evaluated by the PLC test in the three
study groups are recorded in Table 3. After transforming the F
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Table 1
Characteristics of the sample
A B C OLT CG
n 30 30 29 30 31
Sex, F/M 3/27 2/28 2/27 6/24 9/22
Education status
Elementary school 27 23 24 18 24
High school 00 02 04 07 03
College / university 03 05 01 05 04
Age, years 
(mean ± SD) 57.26±9.05 58.06±9.03 55±9.21 54±9 54.70±6
Range (years) 39-73 34-69 35-73 34-69 46-67
Alcoholic 19 20 17 12* –
Viral (B and /or C) 04 04 09 03* –
Alcoholic + Viral 03 04 03 11* –
Others 04 02 00 03* –
HE / HE0 3/27 12/18 20/9 3/27* –
A, B y C= Child-Pugh stage of cirrhosis; OLT= liver transplant recipients; CG= control
group; n= number of subjects. HE / HE0= with / without clinical record of episodes of he-
patic encephalopathy; *Before transplantation.
Table 2
Theoretical dimensions and factorial structure of the PLC
Dimension Ability to function Wellbeing
Physical I. Physical function (8 items) List of symptoms (10-15 items)
Psychological II. Psychological function (8 items) III. Positive mood status (5 items)
IV. Negative mood status (8 items)
Social V. Social function (6 items) VI. Social wellbeing (5 items)
value a Wilk’s Lamba of F= 72.81 (P= 0.00) was obtained and,
consequently, ANOVA was applied individually to each
dimension. 
The Physical Well-being scale (PW) significant differences
were found between the experimental groups and the control
group (A,B,C and OLT vs CG, p= 0.001), and also between the
subgroup of cirrhotic patients in Child-Pugh A and OLT compared
to grade C cirrhotic patients (A and OLT vs C, p= 0.001). In the
Physical Function scale (FF), significant differences were found
between the patient groups and the control group (A, B, C and
OLT vs CG, p= 0.001). In the dimension that measures
Psychological Function (FP), there are significant differences
between the control group and the three groups with hepatic
cirrhosis (A,B,C vs CG, p= 0.001). There were also significant
differences between the cirrhotic group with Child-C and OLT
(OLT vs C, p= 0.001). Significant differences were also observed
in the Positive Mood scale (PM) between the four experimental
groups and the control (A, B, C and OLT vs CG, p= 0.001).
Transplanted patients also presented significant differences in this
dimension compared to the three groups of cirrhotic patients (OLT
vs A,B,C, p= 0.001). There were significant differences in the
Negative Mood dimension (NM) between the Child-C patient
group and the control group (C vs CG, p= 0.001). The
combination of the two scales NM and PM measure so-called
Psychological Wellbeing. 
The social function dimension (SF) there were significant
differences between the four patient groups and the control group
(A, B, C and OLT vs CG, p= 0.001), and also between the
transplanted group and Child-C (OLT vs C, p= 0.001). The last
scale, Social Wellbeing scale (SW), there were no significant
differences between any of the groups (p>0.05).
Discussion
Our results suggest that cirrhotic patients and liver transplant
recipients have a worse quality of life than healthy subjects. Also,
liver transplant recipients appear to have a better quality of life
than cirrhotic patients in most of the dimensions studied (Bravata,
Olkin, Barnato, Keeffe and Owens, 1999). Cirrhotic patients with
Child-A have similar scores to OLT patients in all the scales
measured with the PLC, although these were not identical. In
general, the OLT group had higher scores than the Child-A group
although these differences were not significant; differences may
become significant if a larger sample were studied. 
Most OLT patients showed an improvement in the Physical
Wellbeing (PW) scale. However, these subjects are still on
immunosuppressive maintenance therapy and this could, at least in
part, explain their lower than normal values in the Physical
Function (PF) scale. This scale evaluates the performance capacity
and includes aspects related with corporal and intellectual
functional capacity, the ability to perform intensive tasks, to
concentrate and to cope with routine obligations in daily life and at
work (Siegrits et al., 1996). In our work, cirrhotic patients
presented a worsening of their physical health as the chronic liver
disease progressed (Groeneweg, Quero, De Bruijn, Hartmann,
Essink-Bot, Hop and Schalm, 1998; Wiesinger, Quittan,
Zimmermann, Nuhr, Wichlas, Bodingbaver, Asari, Berlakovich,
Crevenna, Fialka-Moser and Peck-Radosavljevic, 2001). However,
immunosuppressive treatment with cyclosporin A caused
nephrotoxicity and hypertension in 67% of transplant recipients
and some OLT patients developed diabetes, although most patients
achieved good liver function with liver function tests within normal
limits (Eid, Steffen, Porayko, Beers, Kaese, Wiesner and Kiron,
1989; Tarter and Switala, 1991; Leyendecker, Bartholomew,
Neuhaus, Hörhold, Blumbrardt, Neuhaus and Klappo, 1993). 
On the other hand, the Psychological Function dimension of
tests measures the capacity for patients to enjoy themselves and to
relax and the individual’s ability for psychological recovery.
Patients are asked about their ability to relax, the quality of their
sleep, appetite and their ability to enjoy themselves. They are also
asked about their ability to overcome day-to-day disappointments
or setbacks and their ability to improve their own situation
(Siegrits et al., 1996). The OLT patients also have the highest
scores in this section and these differences are significantly better
than those of Child-C patients. It is noteworthy that OLT patients
receive treatment with steroids that can produce irritability,
emotional lability, depression and impaired concentration and
attention (De Bona, Ponton, Ermani, Iemmol, Feltrin, Boccagni,
Gerunda, Naccarato Rupolo and Burra, 2000). However, as well as
post-transplantation palliative treatments, psychological and
social factors can also affect their QOL and are often somatised in
these patients (Nickel et al., 2002). It is important to take into
account the time elapsed since transplantation when evaluating
QOL since these patients pass through a series of post-
transplantation phases. Immediately after transplantation they tend
to be euphoric and later gradually return to normal daily life
(Leyendecker, Bartholomew, Neuhaus, Hörhold, Blumhardt,
Neuhaus and Klappo, 1993; Commander, Neuberger and Dean,
1992). We must bear in mind that most of our patients have had a
recent OLT. This is reflected in the dimensions that evaluate
Positive Mood (PM) and Negative Mood (NM) that together
measure Psychological wellbeing (PsyW). The OLT groups have
significantly better PM scores than the three cirrhotic groups. The
PM as a dimension of the PsyW contains essential aspects of
positive mood such as good mood, emotional stability and
optimism. In contrast, NM, measures essential aspects of negative
mood such as melancholy, agitation, irritation, feelings of being
under threat or despair (Siegrist et al., 1996). Only the Child-C
group presented this type of behaviour with significantly different
results to the control. However, it must be born in mind that these
patients are in a terminal phase of the cirrhosis and fulfil several
criteria to be candidates for OLT. They have similar scores in all
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Table 3
Results of PLC quality of life test
Groups Child-A Child-B Child-C OLT CG p
Physical wellbeing 3.87±0.75a 3.72±0.57a 3.29±0.74a,b 4.13±0.6ª 4.75±0.34 0.001
Physical function 2.42±0.89a 2.24±0.98a 2.07±0.94a 2.56±0.98a 3.61±0.33 0.001
Psychological function 2.67±0.79a 2.82±0.78a 2.34±0.86a,c 3.02±0.84 3.59±0.35 0.001
Positive mood 2.37±0.82a 2.31±0.86a 1.19±0.91a,c 2.74±0.88a 3.52±0.48 0.001
Negative mood 3.21±0.72 3.15±0.57 2.78±0.85a 3.28±0.58 3.56±0.4 0.001
Social function 2.86±0.94a 2.86±0.97a 2.27±1.2a,c 3.09±1a 3.92±0.18 0.001
Social wellbeing 3.58±0.7 3.78±0.4 3.57±0.56 3.8±0.4 3.96±0.21 0.001
Mean ± SE; a Significant differences with the CG; b Significant differences with Child-A and OLT;
c Significant differences with OLT
the scales showing a correspondence between their physical
condition and the other dimensions evaluated (Younossi, Guyatt,
Kiwi, Boparai and King, 1999). Therefore, there are variability
indicators in the QOL that depend on the subjects included in the
study (Bravata el al., 1999; Younossi, Boparai, McCormick, Price
and Guyatt, 2001). Other authors too found a poorer QOL in
cirrhotic patients that worsened with hepatic disease course
(Groeneweg et al., 1998). 
Differences were also observed between patients and controls in
the Social function scale (SF) that assesses the ability to start and
to maintain communication with other people (Siegrist et al.,
1996). Once again OLT patients presented better SF scores than the
cirrhotic group, and this difference was significant between the
OLT and the Child-C group. These results coincide with those
obtained in the previous scales since, as other authors have shown,
the QOL of cirrhotic patients considerably improves post-
transplantation (Collis, Burroughs, Rolles and Lloyd, 1995; Bryan,
Ratcliffe, Neuberger, Burroughs, Gunson and Buxton, 1998).
However, in general, patients with a more severe pre-transplant
Child-Pugh diagnosis tended to have better post-transplantation
QOL levels (Bryan et al., 1998; Geevarghese, Bradley, Wright,
Chapman, Feurer, Payne, Hunter and Pinson, 1998).
The Social Wellbeing scale (SW) measures aspects related with
the social and emotional support the patient receives in the form of
proximity to other persons, their dedication and offers of help and
no feelings of loneliness or exclusion. In this dimension no
significant differences were found either among the patient groups
or between these and the control group. These results emphasise
the importance of health services specialised in caring for these
patients. Hence, as well as the patient’s family and social
environment, close medical supervision by a specialised service
plays an important role in maintaining and improving these
patient’s QOL (Hellgren, Berglund, Gunnarsson, Hansson,
Norberg and Backman, 1998). There is also an OLT support group
that gives information and help during the pre and post-
transplantation phases. 
On the whole, the QOL of these patients is no different from that
of other types of transplant recipients (Lorenzon and Bäckman,
1999). Like other authors, we consider that pre and post-
transplantation programmes offering both social and psychological
support would improve QOL in OLT. Also, routine psychological
and psychiatric tests before during and after transplantation to
assess aspects such as the patient’s personality would help in the
face of a new crisis (Nickel et al., 2002).
In conclusion, we found quality of life in OLT to be
significantly better than in cirrhotic patients although it will
always remain below the levels experienced by the healthy
population.
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